title: [Hepatocellular carcinoma treated with a curative segmentectomy five years after complete remission of acute myeloblastic leukemia].
abstract: Acute myeloblastic leukemia (AML) was diagnosed in a 54-year-old male who had been known to carry a chronic hepatitis B surface antigen (HBsAg) from June, 1983. Prompt remission was achieved with combination chemotherapy of BHAC-DMP. Follow-up maintenance and an intensification of this chemotherapy had been given for five years. He was readmitted to our hospital in March, 1988 because a mass was detected in the right lobe of the liver by ultrasonography. His serum alpha fetoprotein (AFP) level was found to be 180.1 ng/ml, and was diagnosed as having a hepatocellular carcinoma though there was no evidence of liver cirrhosis. A curative right hepatectomy was performed in May, 1988 after transcatheter arterial embolization and portal embolization. After resection of the tumor, the AFP level decreased to 10.7 ng/ml and no HbsAg was detected in the serum.
authors.affiliation: Dept. of Int. Med., Matsuyama Red Cross Hospital.
authors.forename: Y
authors.initials: Y
authors.lastname: Hirota
authors.forename: I
authors.initials: I
authors.lastname: Matsumoto
authors.forename: K
authors.initials: K
authors.lastname: Takata
authors.forename: S
authors.initials: S
authors.lastname: Kondou
authors.forename: T
authors.initials: T
authors.lastname: Aso
authors.forename: H
authors.initials: H
authors.lastname: Hino
authors.forename: S
authors.initials: S
authors.lastname: Nishiura
authors.forename: M
authors.initials: M
authors.lastname: Makuuchi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000601:surgery* / Q000628:therapy; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003630:Daunorubicin / Q000008:administration & dosage; D004621:Embolization, Therapeutic; D006498:Hepatectomy / Q000379:methods; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000276:immunology; D008113:Liver Neoplasms / Q000601:surgery* / Q000628:therapy; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D006514:Hepatitis B Surface Antigens; D003561:Cytarabine; D011239:Prednisolone; D015122:Mercaptopurine; D003630:Daunorubicin